NL-OMON31349尚未招募4 期
Safety and efficacy of efalizumab in combination with methotrexate in patients with severe psoriasis: a comparative study. - Efalizumab methotrexate
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients must be older than 18 years of age.
- •- Patients must have a PASI greater than 10, or a PASI greater than 8 in combination with a Skindex-29 > 35.
- •- Patients must have failed to respond to phototherapy, methotrexate and/or cyclosporin in the past or have a contraindication for using phototherapy or cyclosporin.
排除标准
- •- Patients who have non-plaque forms of psoriasis (eg, erythrodermic, guttate or pustular).
- •- Patients who have current drug-induced psoriasis.
- •- Female patients who are pregnant, nursing and both men and women who are planning pregnancy during the study period or during the six months after receiving the last dose of study medication.
- •- Patients with severe other diseases.
研究者
相似试验
进行中（未招募）
1 期
Safety and efficacy of efalizumab in combination with methotrexate in patients with severe psoriasis: a comparative study.Moderate to severe chronic plaque psoriasisMedDRA version: 9.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisEUCTR2007-001630-14-NLniversity Medical Centre St. Radboud, Department of Dermatology30
招募中
4 期
The effect of empagliflozin in patients with idiopathic edemaIdiopathic edema.Edema, unspecifiedR60.9IRCT20230314057712N1Ahvaz University of Medical Sciences70
进行中（未招募）
不适用
Efficacy ans safety of subcutaneous Efalizumab in the treatment of patients with cutaneous lupus erythematosus: A mono-centre, open-label, prospective pilot study - EFALUPUSCutaneous lupus erythematosus (discoid LE or subacute cutaneous LE) or systemic lupus erythematosus with cutaneous DLE or SCLE lesions without major organ involvment.MedDRA version: 9.1Level: LLTClassification code 10013071Term: Discoid lupus erythematosisMedDRA version: 9.1Level: LLTClassification code 10057903Term: Subacute cutaneous lupus erythematosusMedDRA version: 9.1Level: LLTClassification code 10056509Term: Cutaneous lupus erythematosusEUCTR2008-003833-25-DEniversitätskrankenhaus Schleswig-Holstein17
尚未招募
4 期
Efficacy and Safety of empagliflozin in patients with hepatic ascites: a randomized controlled trialDigestive SystemPACTR202402866059449one60
已完成
2 期
Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseJPRN-jRCT2080225028Takaomi Kessoku100